Insulin in heart development

Given the profound effects of insulin on energy metabolism and gene expression in virtually all tissues, it is not surprising that systemic deficiency in the insulin receptor (IR) leads to the early postnatal death of IR?/? mice. However, Cre/lox technology has also allowed for the creation of animals lacking the IR specifically in particular cell types, and the more subtle phenotypes in these designer mice offer deeper insights into the effects of insulin resistance in specific energy-storing or -consuming organs in the adult animal. Thus, skeletal muscle-specific IR knockout (MIRKO) mice have been available for several years, and animals lacking the receptor in pancreatic b islet cells, hepatocytes, or brown adipose cells have all been described. Belke et al. now add to this list the CIRKO mouse, which lacks the IR specifically in cardiomyocytes. In young CIRKO animals, the heart is of normal structure but is reduced in size, apparently because the cells themselves remain small. Indeed, CIRKO cardiomyocytes appear immature in several other respects, particularly their preferential use of glucose, rather than fatty acids, as a metabolic fuel and their continued high expression of the b isoform of the myosin heavy chain, which is normally suppressed after fetal development. Interestingly, one well established effect of insulin in the heart, the activation of glucose oxidation, is maintained in CIRKO animals. The authors speculate that endothelial cells or some other insulin-responsive cardiac cell type is responsible for inducing this metabolic change in the cardiac muscle, perhaps as a secondary effect of enhanced eNOS activity. Testing such a model might require the generation of yet another cell type specific IR knockout mouse, this one targeting the endothelium.


Contact: John Ashkenas
Journal of Clinical Investigation

Page: 1

Related biology news :

1. Insulin-producing pancreatic cells are replenished by duplication
2. Insulin study sheds light on physics of crystal growth
3. Insulin-degrading enzyme may affect risk of Alzheimers disease
4. Insulin in worms
5. In The Genes: Extra Belly Fat, Insulin Resistance Linked
6. Researchers Identify And Isolate First Gene For A Form Of Insulin-Dependent Diabetes
7. Space Grown Insulin Crystals Provide New Data On Diabetes
8. Cellular Short Circuit Causes Insulin Resistance
9. Insulin Resistance Is A Risk Factor For Atherosclerosis In Whites And Hispanics
10. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
11. Screen siblings, parents of infants with severe heart abnormalities

Post Your Comments:

(Date:5/2/2019)... (PRWEB) , ... April 30, 2019 , ... ... Nadel LLP is pleased to announce that Gunes Bender, Ph.D., a registered ... life sciences practice group. In his new role, Bender provides technical support and ...
(Date:5/2/2019)... ... May 01, 2019 , ... uBiome, the leader ... Rakow, the Company’s General Counsel, as Interim Chief Executive Officer of uBiome, effective ... on administrative leave. There will also be an independent investigation into uBiome’s billing ...
(Date:4/25/2019)... HARBOR TOWNSHIP, N.J. (PRWEB) , ... April 23, ... ... of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device ... state of art manufacturing facility in Egg Harbor Township, New Jersey. The new ...
Breaking Biology News(10 mins):
(Date:4/25/2019)... ... April 24, 2019 , ... ... for sales and service organizations, today announced global availability of Inference Studio’s latest ... enterprises of all sizes to harness the power of Google’s Contact Center ...
(Date:4/15/2019)... ... 15, 2019 , ... Sirrus, Inc., a developer of novel ... expansion to increase production of methylene malonate monomers and oligomers. , The expanded ... full-scale production facility, which is scheduled to break ground in 2019. “The expanded ...
(Date:4/9/2019)... ... April 09, 2019 , ... USDM Life ... of life sciences organizations to accelerate innovation and maximize productivity, announces that nearly ... past 12 months. , USDM’s Cloud Assurance is a managed subscription ...
(Date:4/8/2019)... ... 2019 , ... US Capital Global Securities , an affiliate of US ... the privately held pharmaceutical company, S1 Biopharma (“S1”). , S1 has a pipeline of ... sexual dysfunction disorder and is ready to begin phase 2b trials. In phase 2a ...
Breaking Biology Technology:
Cached News: